VYGR
Voyager Therapeutics Inc
NASDAQ: VYGR · HEALTHCARE · BIOTECHNOLOGY
$3.73
+2.47% today
Updated 2026-04-30
Market cap
$224.69M
P/E ratio
—
P/S ratio
5.57x
EPS (TTM)
$-2.04
Dividend yield
—
52W range
$3 – $6
Volume
0.7M
Voyager Therapeutics Inc (VYGR) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
-2.6%
Last 4 quarters
Revenue YoY growth
+144.3%
Most recent quarter
EPS YoY growth
+20.3%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+9.4%
Last 2 reports
Positive reaction rate
100%
2 of 2 quarters
Largest single-day move
+18.0%
2026-03-10
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-10 | $-0.47 | +7.9% | $4.11 | $4.85 | +18.0% |
| 2025-11-10 | $-0.47 | +9.6% | $4.23 | $4.26 | +0.7% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.51 | $-0.47 | +7.9% | $15.34M | +144.3% |
| 2025-09-30 | $-0.52 | $-0.47 | +9.6% | $13.37M | -45.7% |
| 2025-06-30 | $-0.53 | $-0.57 | -7.5% | $5.20M | -82.4% |
| 2025-03-31 | $-0.44 | $-0.53 | -20.5% | $6.47M | -66.8% |
| 2024-12-31 | $-0.35 | $-0.59 | -68.4% | $6.28M | -93.0% |
| 2024-09-30 | $-0.45 | $-0.16 | +64.4% | $24.63M | +433.8% |
| 2024-06-30 | $-0.41 | $-0.18 | +56.1% | $29.58M | +509.5% |
| 2024-03-31 | $-0.44 | $-0.20 | +54.5% | $19.52M | -87.0% |
| 2023-12-31 | $-0.29 | $1.25 | +531.0% | $90.06M | — |
| 2023-09-30 | $-0.58 | $-0.59 | -1.7% | $4.61M | — |
| 2023-06-30 | $-0.57 | $-0.51 | +10.5% | $4.85M | — |
| 2023-03-31 | $0.77 | $2.94 | +281.8% | $150.48M | — |
Frequently asked questions
Has Voyager Therapeutics Inc beaten earnings estimates?
Voyager Therapeutics Inc has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of -2.6% over the last 4 quarters.
How does VYGR stock react to earnings?
VYGR stock has moved an average of +9.4% in the trading day following earnings over its last 2 reports, with positive reactions in 100% of those quarters.
What is Voyager Therapeutics Inc's revenue growth rate?
Voyager Therapeutics Inc reported year-over-year revenue growth of +144.3% in its most recent quarter, with EPS growing +20.3% year-over-year.